Literature DB >> 4434322

Regression of an adrenal cortical carcinoma and its neovascular bed following mitotane therapy: a case report.

V Downing, J Eule, R A Huseby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4434322     DOI： 10.1002/1097-0142(197412)34:6<1882::aid-cncr2820340605>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  4 in total

1.  O,p'-DDD (mitotane) levels in plasma and tissues during chemotherapy and at autopsy.

Authors:  H von Slooten; A P van Seters; D Smeenk; A J Moolenaar
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  Survival rates and prognostic factors in adrenocortical carcinoma.

Authors:  P Icard; A Louvel; Y Chapuis
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

3.  Oral and vulvo-vaginal lichenoid reactions due to mitotane (Lysodren): A case report.

Authors:  Arthur Schmouchkovitch; Héloïse Herry; Philippe Thuillier; Véronique Kerlan; Camille Fleuret; Guy Le Toux; Sylvie Boisramé
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

4.  Rapid and Complete Remission of Metastatic Adrenocortical Carcinoma Persisting 10 Years After Treatment With Mitotane Monotherapy: Case Report and Review of the Literature.

Authors:  Nada El Ghorayeb; Geneviève Rondeau; Mathieu Latour; Christian Cohade; Harold Olney; André Lacroix; Paul Perrotte; Alexis Sabourin; Tania L Mazzuco; Isabelle Bourdeau
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.